AbCellera Biologics Inc. ABCL Canada — Funding commitment received
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by AbCellera Biologics Inc. in its filing.
Tagged under the XBRL concept abcl:GovernmentAssistanceAwardAmountOtherExpenses.
The source filing: AbCellera Biologics Inc.’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 4:28 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001703057-26-000046
3The funding includes repayable and conditionally repayable amounts starting in 2033 over 15 years, where the conditional portion is based on certain revenue thresholds, at a factor of up to 1.4 times the original grant. As of June 30, 2026, total available undrawn grant funding was approximately CAD $103.1 million ($72.7 million), consisting of CAD $84.5 million ($59.5 million) for future qualifying expenditures and $13.2 million in accrued grants receivable for which claims will be filed subsequently.
Item 1. Financial Statements (Unaudited)
FAQ
- What is AbCellera Biologics Inc.'s canada — funding commitment received?
- AbCellera Biologics Inc. (ABCL) reported canada — funding commitment received of $84.5M in Q2 2026.
- What does canada — funding commitment received mean?
- Reflects the total value of financial commitments or grants formally pledged to the Canadian segment by government or external entities. This metric is a key indicator of the company's ability to secure external non-dilutive capital to support its research and development initiatives.
Ask your AI about AbCellera Biologics Inc.'s canada — funding commitment received.
Connect your AI assistant and compare it to peers, right in your chat.
